{"id":236822,"date":"2022-01-17T08:00:00","date_gmt":"2022-01-17T08:00:00","guid":{"rendered":"https:\/\/eu.intelligentlabs.org\/pazinimo-nuosmukis\/"},"modified":"2022-01-17T08:00:00","modified_gmt":"2022-01-17T08:00:00","slug":"pazinimo-nuosmukis","status":"publish","type":"post","link":"https:\/\/eu.intelligentlabs.org\/lt-lt\/pazinimo-nuosmukis\/","title":{"rendered":"Pa\u017einimo nuosmukis \u2013 ar fosfatidilserinas gali pad\u0117ti?"},"content":{"rendered":"\r\n<p>&nbsp;<\/p>\r\n\r\n<p>Mums senstant, m\u016bs\u0173 neuron\u0173 sveikata nuolat prast\u0117ja. Anks\u010diau ar v\u0117liau dauguma \u017emoni\u0173 pradeda jausti lengvus simptomus: trumpalaik\u0117 atmintis pasidaro nebe tokia ai\u0161ki, kaip anks\u010diau, o prisiminti seniau pa\u017einotus vardus ir veidus tampa vis didesniu i\u0161\u0161\u016bkiu.<strong> Tai nat\u016brali sen\u0117jimo dalis, vadinama pa\u017einimo nuosmukiu.<\/strong>\u00a0<\/p>\r\n\r\n\r\n\r\n<p>Laiming\u0173, sveik\u0173 ir puikiai veikian\u010di\u0173 smegen\u0173 l\u0105stel\u0117s gali efektyviai susijungti arba \u201ekalb\u0117tis\u201c tarpusavyje. Smegen\u0173 l\u0105steli\u0173 jungtis vadinama \u201esinapse\u201c, o visos l\u0105stel\u0117s m\u016bs\u0173 smegen\u0173 ir centrin\u0117je nerv\u0173 sistemoje naudoja sinapses mums kalbant, judant, mokantis ir prisimenant. Visgi, mums senstant, m\u016bs\u0173 smegen\u0173 l\u0105stel\u0117s (neuronai) pradeda mirti, o i\u0161liekantys neuronai tampa ma\u017eiau sveikais ir po truput\u012f praranda savo geb\u0117jimus susijungti su kitais juos supan\u010diais neuronais.<\/p>\r\n\r\n\r\n\r\n<p>Akivaizdu, kad pa\u017einimo nuosmukis n\u0117ra gerai ir gali labai paveikti m\u016bs\u0173 gyvenimus. Visgi, jei nesustabdysime degeneracijos, grei\u010diausiai pasieksime kit\u0105 \u0161io proceso faz\u0119 &#8211; <strong>pa\u017einimo sutrikim\u0105. <\/strong>Tai kiek rimtesn\u0117 b\u016bkl\u0117, rei\u0161kianti, kad \u017emon\u0117s nei\u0161pildo viso savo potencialo, bet vis dar gali gyventi palyginti \u012fprastai ir nepriklausomai.<\/p>\r\n\r\n\r\n\r\n<p>Ta\u010diau b\u016bklei progresuojant ir pasiekus tam tikr\u0105 ta\u0161k\u0105, pasiekiama <strong>demencija, <\/strong>kuri rei\u0161kia, kad \u012fprastos kasdien\u0117s u\u017eduotys taps problema, o mums jau nebepavyks gyventi be pagalbos. 60 &#8211; 80 % <a href=\"https:\/\/en.wikipedia.org\/wiki\/Dementia\" rel=\"noopener\">demencijos<\/a> atvej\u0173 yra susij\u0119 su Alzheimerio liga.<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-large is-style-default\"><img decoding=\"async\" class=\"wp-image-74962\" src=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2022\/01\/image-1024x573.jpeg\" alt=\"laiminga vyresni\u0173 \u017emoni\u0173 pora\r\n\r\n\" \/><\/figure>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><strong>L\u0105steli\u0173 membranos ir pa\u017einimo nuosmukis<\/strong><\/h2>\r\n\r\n\r\n\r\n<p><strong>Demencija <\/strong>yra terminas, skirtas apibendrinti grupei sveikatos sutrikim\u0173 ir lig\u0173, d\u0117l kuri\u0173 ilgainiui kyla <strong>pa\u017einimo funkcij\u0173 <\/strong>(atminties, elgesio, kalbos, problem\u0173 sprendimo ir sprendim\u0173 pri\u0117mimo)<strong> nuosmukis<\/strong>, paveikiantis kasdien\u012f gyvenim\u0105.<\/p>\r\n\r\n\r\n\r\n<p>Ilgus metus trukusi\u0173 tyrim\u0173 metu, mokslininkai atskleid\u0117 kelias skirtingas demencijos prie\u017eastis, o reik\u0161mingiausia i\u0161 j\u0173 &#8211; m\u016bs\u0173 smegen\u0173 l\u0105steles supan\u010di\u0173 ir apsaugan\u010di\u0173 membran\u0173 strukt\u016bros pokytis, kylantis d\u0117l deformuot\u0173 baltym\u0173 sankaup\u0173, ir sukeliantis progresuojant\u012f pa\u017einimo nuosmuk\u012f, ilgainiui virstant\u012f demencija.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><strong>Kas yra l\u0105steli\u0173 membranos?<\/strong><\/h3>\r\n\r\n\r\n\r\n<p>M\u016bs\u0173 l\u0105steli\u0173 membranos yra sudarytos i\u0161 dviej\u0173 lipid\u0173 sluoksni\u0173, dar \u017einom\u0173 kaip lipid\u0173 dvisluoksnis, o m\u016bs\u0173 l\u0105stel\u0117ms senstant, jie traukiasi, o lipid\u0173 dvisluoksnio sandara kei\u010diasi.<\/p>\r\n\r\n\r\n\r\n<p>Normaliai, l\u0105stel\u0117s tur\u0117t\u0173 b\u016bt\u0173 putlios, takios, tamprios ir lanks\u010dios &#8211; tai leid\u017eia joms efektyviai priimti sinaps\u0117s signalus i\u0161 kit\u0173 l\u0105steli\u0173 bei u\u017etikrinti pralaidum\u0105, \u0161itaip leid\u017eiant jud\u0117ti visiems baltymams, fermentams, maistin\u0117ms med\u017eiagoms, deguoniui, gliukozei ir kitoms med\u017eiagoms \u012f ir i\u0161 l\u0105stel\u0117s.<\/p>\r\n\r\n\r\n\r\n<p>Visgi, membranoms prarandant putlum\u0105 ir takum\u0105, jos tampa kietesn\u0117s, o kartu ir ma\u017eiau pralaid\u017eios, bei sunkiau prisitaiko prie gaunam\u0173 sinaps\u0117s signal\u0173. Galite jas \u012fsivaizduoti kaip apelsin\u0105, kuris prad\u017eioje b\u016bna putlus ir sultingas, bet, jam prarandant dr\u0117gm\u0119, i\u0161saus\u0117ja ir pasidaro kietas.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><strong>Kas yra lipid\u0173 dvisluoksnis?<\/strong><\/h3>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-full is-style-default\"><img decoding=\"async\" class=\"wp-image-74965\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2018\/02\/phosphatidylserine-the-most-effective-natural-nootropic-01.gif\" alt=\"fosfatidilserino membrana\r\n\" \/ class=\"wp-image-132170\">\r\n<figcaption>L\u0105steli\u0173 membran\u0173 fosfolipidinis dvisluoksnis<\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n<p>Lipid\u0173 dvisluoksniai sudaryti i\u0161 fosfatidilcholino, fosfatidiletanolamino, sfingomielino (fosfatidilcholino ir fosfatidiletanolamino junginys), fosfatidilserino ir omega-3 riebi\u0173j\u0173 r\u016bg\u0161\u010di\u0173 DHA.<\/p>\r\n\r\n\r\n\r\n<p>Lygiai kaip ir fosfatidilcholinas, fosfatidiletanolaminas yra labai svarbus membranos strukt\u016brai: pana\u0161iai kaip plieno r\u0117mai svarb\u016bs pastatui. O \u0161tai <strong>fosfatidilserinas ir DHA u\u017etikrina, kad l\u0105stel\u0117s b\u016bt\u0173 itin takios ir lanks\u010dios.<\/strong><\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><strong>Kaip sen\u0117jimas veikia lipid\u0173 dvisluoksnius?<\/strong><\/h3>\r\n\r\n\r\n\r\n<p><strong>Mums senstant, fosfatidilcholino kiekis membranose ma\u017e\u0117ja<\/strong>, o cholesterolio &#8211; did\u0117ja (1,3). \u0160is pokytis yra pagrindin\u0117 didesnio l\u0105steli\u0173 membran\u0173 kietumo ir ma\u017eesnio j\u0173 takumo ir lankstumo prie\u017eastis.<\/p>\r\n\r\n\r\n\r\n<p>D\u0117l \u0161ios prie\u017easties suma\u017e\u0117ja ferment\u0173 aktyvumas, o baltymai ir kitos maistin\u0117s med\u017eiagos nebegali taip lengvai keliauti \u012f ir i\u0161 l\u0105stel\u0117s. Taigi, l\u0105stel\u0117s tiesiog nebegali efektyviai komunikuoti su kitomis l\u0105stel\u0117mis (1,4,5).<\/p>\r\n\r\n\r\n\r\n<p>Laimei, <strong>\u0161io fosfatidilserino lygio smukimo galime i\u0161vengti naudodami paprastus fosfatidilserino papildus. <\/strong>Fosfatidilserino papildai yra lengvai \u012fsisavinami (jei tik juos vartojate su maistu, kuriame yra riebal\u0173!) ir gali nesunkiai kirsti kraujo-smegen\u0173 barjer\u0105 bei pasiekti smegenis, kur bus pasisavintos neuron\u0173 membran\u0173 (6).<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><strong>Kaip fosfatidilserinas padeda suma\u017einti pa\u017einimo nuosmuk\u012f?<\/strong><\/h2>\r\n\r\n\r\n\r\n<p>Patekus \u012f neuron\u0173 membranas, <strong>fosfatidilserinas gali sul\u0117tinti, sustabdyti ar net atkurti \u012fvykusius strukt\u016brinius ir biocheminius poky\u010dius <\/strong>bei atkurti smegen\u0173 l\u0105steli\u0173 membran\u0173 lankstum\u0105 ir takum\u0105.<\/p>\r\n\r\n\r\n\r\n<p>Tai pagerina pa\u017einimo funkcijas, leid\u017eian\u010dias mums:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li><strong>kurti naujus <\/strong>trumpalaikius atsiminimus,\u00a0<\/li>\r\n<li><strong>sustiprinti ilgalaikius atsiminimus<\/strong>,<\/li>\r\n<li><strong>atkurti prisiminimus,<\/strong><\/li>\r\n<li>ir <strong>kurti visi\u0161kai naujus.<\/strong><\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>Tai taip pat gerina m\u016bs\u0173 geb\u0117jimus:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>mokytis,<\/li>\r\n<li>sutelkti d\u0117mes\u012f,<\/li>\r\n<li>susikoncentruoti,<\/li>\r\n<li>suprasti ir spr\u0119sti problemas.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>Galime pagerinti savo kalb\u0117jimo \u012fg\u016bd\u017eius ir komunikavimo geb\u0117jimus bei jud\u0117jimo funkcijas, o ypa\u010d greit\u0105 m\u016bs\u0173 reakcij\u0105 ir refleksus (6).<\/p>\r\n\r\n\r\n\r\n<p>Fosfatidilserino papild\u0173 vartojimas taip pat pagerina nerv\u0173 augimo faktoriaus, hormono, skatinan\u010dio nauj\u0173 sveik\u0173 nerv\u0173 l\u0105steli\u0173 augim\u0105 ir sen\u0173, pa\u017eeist\u0173 l\u0105steli\u0173 pa\u0161alinim\u0105, atpalaidavim\u0105 (7). <a href=\"https:\/\/www.intelligentlabs.org\/phosphatidylserine-ultimate-supplement-guide\/\">Fosfatidilserinas taip pat apsaugo membranas<\/a> nuo laisv\u0173j\u0173 radikal\u0173 ir oksidacinio poveikio bei skatina m\u016bs\u0173 antioksidacin\u0117s gynybos sistem\u0173 augim\u0105 (8).<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-large is-style-default\"><img decoding=\"async\" class=\"wp-image-74963\" src=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2022\/01\/image-01-1024x570.jpeg\" alt=\"maloni vyresn\u0117 pora, besim\u0117gaujanti saul\u0117lyd\u017eiu\r\n\" \/><\/figure>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><strong>Fosfatidilserino, pa\u017einimo nuosmukio ir pa\u017einimo sutrikimo tyrimai<\/strong><\/h2>\r\n\r\n\r\n\r\n<p><strong>Tyrimas Nr. 1 \u2013 atvirieji tyrimai<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Atvir\u0173j\u0173 tyrim\u0173 metu (pvz. tyrim\u0173, kai tiek tiriamieji, tiek mokslininkai \u017eino, kad tiriamieji gauna fosfatidilserino), vyresnio am\u017eiaus \u017emon\u0117s su nedideliu pa\u017einimo nuosmukiu, 60 dien\u0173 vartojo 300 mg fosfatidilserino (100 mg, 3 kartus per dien\u0105).<\/p>\r\n\r\n\r\n\r\n<p>60 dien\u0173 periodui pasibaigus, tiriamieji \u017eenkliai geriau pasirod\u0117 mokymosi \u017eod\u017eiu, \u017eodin\u0117s atminties, kalbos sklandumo, vaizdinio mokymosi, d\u0117mesio, komunikacijos \u012fg\u016bd\u017ei\u0173, iniciatyvos, socializacijos ir savaranki\u0161kumo testuose (9,10).<\/p>\r\n\r\n\r\n\r\n<p><strong>Tyrimas Nr. 2 &#8211; 90 dien\u0173 tyrimas<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Kito tyrimo, kurio trukm\u0117 buvo prailginta iki 90 dien\u0173, metu buvo u\u017efiksuoti labai pana\u0161\u016bs rezultatai, ta\u010diau tiriamieji taip pat geb\u0117jo geriau prisiminti vardus ir atpa\u017einti veidus (11).<\/p>\r\n\r\n\r\n\r\n<p>Kita vyresnio am\u017eiaus \u017emoni\u0173 grup\u0117, kent\u0117jusi nuo \u017eenklaus pa\u017einimo nuosmukio, tyrimo pabaigoje pasiek\u0117 puiki\u0173 rezultat\u0173: 3 kartus per dien\u0105 vartojant t\u0105 pa\u010di\u0105 100 mg doz\u0119, u\u017efiksuotas \u017eenklus mokymosi \u017eod\u017eiu, \u017eodin\u0117s atminties, d\u0117mesio trukm\u0117s, geb\u0117jimo susikoncentruoti, budrumo, iniciatyvos, socializacijos ir savaranki\u0161kumo pager\u0117jimas.\u00a0<\/p>\r\n\r\n\r\n\r\n<p><strong>Tyrimas Nr. 3 \u2013 dvigubai aklas tyrimas<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Dvigubai aklame tyrime (kai nei tiriamieji, nei tyr\u0117jai ne\u017eino, kurie tiriamieji gauna fosfatidilserin\u0105, o kurie &#8211; placeb\u0105) dalyvavo vyresni nei 60 met\u0173 vyrai ir moterys, tur\u0117j\u0119 nusiskundim\u0173 d\u0117l lengvo atminties praradimo. 90 dien\u0173 jie kasdien vartojo 300 mg fosfatidilserino.<\/p>\r\n\r\n\r\n\r\n<p>Mokslininkai nustat\u0117, kad fosfatidilserin\u0105 vartojusios grup\u0117s trumpalaik\u0117 atmintis, tiesiogin\u0117 atmintis, \u017eodynas, \u017eod\u017ei\u0173 atsiminimas, d\u0117mesio trukm\u0117 ir budrumas \u017eenkliai pager\u0117jo. Kita vertus, placeb\u0105 vartojusioje grup\u0117je neu\u017efiksuoti jokie teigiami poky\u010diai (14).<\/p>\r\n\r\n\r\n\r\n<p><strong>Tyrimas Nr. 4 \u2013 dvigubai aklas tyrimas, kurio metu tirtas \u017eenklus pa\u017einimo nuosmukis<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Kiti du dvigubai akli tyrimai tyr\u0117 \u017emones, kentusius d\u0117l \u017eenklaus pa\u017einimo sutrikimo (14) bei silpnos degeneracin\u0117s demencijos (15). Mokslininkai nustat\u0117, kad tiriam\u0173j\u0173 \u017eodin\u0117 atmintis ir bendra pa\u017einimo funkcija \u017eenkliai pager\u0117jo. Jie taip pat u\u017efiksavo d\u0117l fosfatidilserino vartojimo \u017eenkliai suma\u017e\u0117jus\u012f atsitraukim\u0105 ir apatiij\u0105 nei placeb\u0105 vartojusioje grup\u0117je.<\/p>\r\n\r\n\r\n\r\n<p>S\u0117kming\u0173 mokslini\u0173 tyrim\u0173 metu u\u017efiksuota fosfatidilserino \u012ftaka smegen\u0173 funkcijai ir pa\u017einimo nuosmukio suma\u017einimui buvo pripa\u017einta ir JAV Maisto ir vaist\u0173 administracijos (FDA), kuri teigia:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>\u201efosfatidilserino vartojimas gali suma\u017einti vyresni\u0173 \u017emoni\u0173 demencijos rizik\u0105\u201c ir<\/li>\r\n<li>\u201efosfatidilserino vartojimas gali suma\u017einti vyresni\u0173 \u017emoni\u0173 pa\u017einimo disfunkcijos rizik\u0105\u201c (16).<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-large is-style-default\"><img decoding=\"async\" class=\"wp-image-74964\" src=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2022\/01\/cognitive-decline-can-phosphatidylserine-help-04-1024x553.jpeg\" alt=\"i\u0161venkite pa\u017einimo nuosmukio su fosfatidilserinu\" \/><\/figure>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><strong>Magi\u0161ka piliul\u0117 neegzistuoja<\/strong><\/h2>\r\n\r\n\r\n\r\n<p>Visgi, reik\u0117t\u0173 pabr\u0117\u017eti, kad fosfatidilserinas n\u0117ra magi\u0161ka piliul\u0117. <strong>Jis labiausiai tinka \u017emon\u0117ms, ie\u0161kantiems b\u016bdo u\u017ekirsti keli\u0105 pa\u017einimo nuosmukiui,<\/strong> arba tiems, kuriems jau pasirei\u0161k\u0117 \u0161veln\u016bs ar vidutiniai pa\u017einimo funkcijos sutrikimai.<\/p>\r\n\r\n\r\n\r\n<p>Pavyzd\u017eiui, vieno tyrimo metu, Alzheimerio liga sergantiems pacientams kasdien buvo duodama 400 mg fosfatidilserino. Mokslininkai nustat\u0117, kad, nors \u0161io papildo vartojimas bei 16 savai\u010di\u0173 trukusi pa\u017einimo mokymosi programa pad\u0117jo daug labiau pagerinti tiriam\u0173j\u0173 neuropsichologini\u0173 test\u0173 rezultatus nei tik pa\u017einimo mokymosi programa, fosfatidilserinas nepad\u0117jo sustabdyti ligos progresavimo. Jie taip pat nustat\u0117, kad po 4 m\u0117nesi\u0173, vis dar vartojant fosfatidilserino papildus, j\u0173 rezultatai pablog\u0117jo (17).\u00a0<\/p>\r\n\r\n\r\n\r\n<p>Visiems, ie\u0161kantiems b\u016bdo i\u0161vengti pa\u017einimo nuosmukio ar pad\u0117ti sul\u0117tinti jo progres\u0105, rekomenduojame pabandyti <a href=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/produktas\/fosfatidilserinas-100mg\/\">fosfatidilserino papild\u0105, kurio si\u016blome vartoti po 100 mg, 3 kartus per dien\u0105<\/a>.<\/p>\r\n\r\n\r\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>\u201c\u0160altiniai\u201d<\/summary>\n\n<p>(2) Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC. Effects of phosphatidylserine in age-associated memory impairment. Neurology 1991;41:644\u20139.<\/p>\n\n\n\n<p>(3) Crook T, Petrie W, Wells C, Massari DC. Effects of phosphatidylserine in Alzheimer\u2019s disease. Psychopharmacol Bull 1992;28:61\u20136.<\/p>\n\n\n\n<p>(4) Kim, Hee-Yong &amp; Huang, Bill &amp; Spector, Arthur. (2014). Phosphatidylserine in the Brain: Metabolism and Function. Progress in lipid research. 56. 10.1016\/j.plipres.2014.06.002.<\/p>\n\n\n\n<p>(5) Marra C, Silveri MC, Gainotti G. Predictors of cognitive decline in the early stage of probable Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 2000;11:212\u20138.<\/p>\n\n\n\n<p>(6) Michael J. Glade Ph.D., Kyl Smith D.C., Phosphatidylserine and the human brain, Nutrition 31 (2015) 781\u2013786<\/p>\n\n\n\n<p>(7) De Simone R., Ajmone-Cat M.A., Tirassa P., Minghetti L. Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells. Journal of Neuropathology and Experimental Neurology. 2003 Feb;62(2):208-16.<\/p>\n\n\n\n<p>(8) Chaung HC, Chang CD, Chen PH, Chang CJ, Liu SH, Chen CC. Docosahexaenoic acid and phosphatidylserine improves the antioxidant activities in vitro and in vivo and cognitive functions of the developing brain. Food Chem 2013;138:342\u20137<\/p>\n\n\n\n<p>(9) Sinforiani E, Agostinis C, Merlo P, Gualtieri S, Mauri M, Mancuso A. Cognitive decline in ageing brain. Therapeutic approach with phosphatidylserine. Clin Trials J 1987;24:115\u201325.<\/p>\n\n\n\n<p>(10) Caffara P, Santamaria V. The effects of phosphatidylserine in patients with mild cognitive decline. An open trial. Clin Trials J 1987;24:109\u201314.<\/p>\n\n\n\n<p>(11) Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B. An open trial of plant-source derived phosphatidylserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci 2000;37:302\u20137.<\/p>\n\n\n\n<p>(12) Granata Q, DiMichele J. Phosphatidylserine in elderly patients. An open trial. Clin Trials J 1987;24:99\u2013103.<\/p>\n\n\n\n<p>(13) Allegro L, Favaretto V, Ziliotto G. Oral phosphatidylserine in elderly patients with cognitive deterioration. An open study. Clin Trials J 1987;24:104\u20138.<\/p>\n\n\n\n<p>(14) Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993;5:123\u201333.<\/p>\n\n\n\n<p>(15) Villardita C, Grioli S, Salmeri G, Nicoletti F, Pennisi G. Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration. Clin Trials J 1987;24:84\u201393.<\/p>\n\n\n\n<p>(16) Taylor CL. Letter regarding phosphatidylserine and cognitive dysfunction and dementia. Bethesda, MD: US Food and Drug Administration; 2003.<\/p>\n\n\n\n<\/details>\n\n<\/div>\n \n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Mums senstant, m\u016bs\u0173 neuron\u0173 sveikata nuolat prast\u0117ja. Anks\u010diau ar v\u0117liau dauguma \u017emoni\u0173 pradeda jausti lengvus simptomus: trumpalaik\u0117 atmintis pasidaro nebe tokia ai\u0161ki, kaip anks\u010diau, o prisiminti seniau pa\u017einotus vardus ir veidus tampa vis didesniu i\u0161\u0161\u016bkiu. Tai nat\u016brali sen\u0117jimo dalis, vadinama pa\u017einimo nuosmukiu.\u00a0 Laiming\u0173, sveik\u0173 ir puikiai veikian\u010di\u0173 smegen\u0173 l\u0105stel\u0117s gali efektyviai susijungti arba \u201ekalb\u0117tis\u201c&#8230;<\/p>\n","protected":false},"author":2,"featured_media":154696,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[3015],"tags":[3033],"coauthors":[],"class_list":["post-236822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mityba","tag-fosfatidilserinas"],"taxonomy_info":{"category":[{"value":3015,"label":"Mityba"}],"post_tag":[{"value":3033,"label":"Fosfatidilserinas"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/declin-cognitif-la-phosphatidylserine-peut-elle-aider-01.jpg",883,476,false],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lt-lt\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":3015,"name":"Mityba","slug":"mityba","term_group":0,"term_taxonomy_id":3015,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":3015,"category_count":45,"category_description":"","cat_name":"Mityba","category_nicename":"mityba","category_parent":0}],"tag_info":[{"term_id":3033,"name":"Fosfatidilserinas","slug":"fosfatidilserinas","term_group":0,"term_taxonomy_id":3033,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"}],"wpml":{"language":"lt-lt","is_original":false,"original_post_id":132046,"translations":{"bg-bg":{"id":225770,"language":"bg-bg","is_original":false},"cs-cz":{"id":220931,"language":"cs-cz","is_original":false},"da-dk":{"id":222513,"language":"da-dk","is_original":false},"de-at":{"id":169379,"language":"de-at","is_original":false},"de-de":{"id":146711,"language":"de-de","is_original":false},"el-cy":{"id":229273,"language":"el-cy","is_original":false},"el-gr":{"id":228450,"language":"el-gr","is_original":false},"en-gb":{"id":132046,"language":"en-gb","is_original":true},"en-ie":{"id":166704,"language":"en-ie","is_original":false},"es-es":{"id":74713,"language":"es-es","is_original":false},"et-ee":{"id":230250,"language":"et-ee","is_original":false},"fi-fi":{"id":238665,"language":"fi-fi","is_original":false},"fr-fr":{"id":75037,"language":"fr-fr","is_original":false},"hu-hu":{"id":225141,"language":"hu-hu","is_original":false},"it-it":{"id":146183,"language":"it-it","is_original":false},"lt-lt":{"id":236822,"language":"lt-lt","is_original":false},"lv-lv":{"id":230620,"language":"lv-lv","is_original":false},"nl-nl":{"id":176264,"language":"nl-nl","is_original":false},"ro-ro":{"id":253665,"language":"ro-ro","is_original":false},"sk-sk":{"id":238831,"language":"sk-sk","is_original":false},"sl-si":{"id":239013,"language":"sl-si","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/236822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/comments?post=236822"}],"version-history":[{"count":0,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/236822\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media\/154696"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media?parent=236822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/categories?post=236822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/tags?post=236822"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/coauthors?post=236822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}